CN106644656A - Hematoxylin-eosin one-step dyeing method - Google Patents
Hematoxylin-eosin one-step dyeing method Download PDFInfo
- Publication number
- CN106644656A CN106644656A CN201710009899.7A CN201710009899A CN106644656A CN 106644656 A CN106644656 A CN 106644656A CN 201710009899 A CN201710009899 A CN 201710009899A CN 106644656 A CN106644656 A CN 106644656A
- Authority
- CN
- China
- Prior art keywords
- hematoxylin
- staining
- eosin
- dyeing
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004043 dyeing Methods 0.000 title abstract description 22
- 238000000034 method Methods 0.000 title abstract description 16
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 claims abstract description 42
- 210000000805 cytoplasm Anatomy 0.000 claims abstract description 20
- 230000001575 pathological effect Effects 0.000 claims abstract description 12
- 239000007853 buffer solution Substances 0.000 claims abstract description 11
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000010186 staining Methods 0.000 claims description 45
- 230000004069 differentiation Effects 0.000 claims description 12
- 239000012192 staining solution Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000007447 staining method Methods 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 230000018044 dehydration Effects 0.000 claims description 4
- 238000006297 dehydration reaction Methods 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000006174 pH buffer Substances 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000007800 oxidant agent Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000243 solution Substances 0.000 abstract description 8
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 238000010827 pathological analysis Methods 0.000 abstract description 4
- 230000002349 favourable effect Effects 0.000 abstract description 3
- 210000004748 cultured cell Anatomy 0.000 abstract description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 210000004940 nucleus Anatomy 0.000 description 19
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 239000000981 basic dye Substances 0.000 description 4
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 238000012303 cytoplasmic staining Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 239000000980 acid dye Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000012758 nuclear staining Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000012151 immunohistochemical method Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 125000004151 quinonyl group Chemical group 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
技术领域technical field
本发明涉及苏木素-伊红染色液及其染色方法,属于病理常规制片常规染色试剂及试剂的使用方法。The invention relates to a hematoxylin-eosin staining solution and a staining method thereof, which belong to conventional staining reagents for routine pathological film production and methods for using the reagents.
背景技术Background technique
苏木素-伊红染色(简称HE染色)是病理学常规制片中最基本、最重要的染色方法,临床应用广泛。苏木素为碱性染料,能将细胞核染成蓝色;伊红为酸性染料,能将细胞质染成红色。在病理诊断、教学和科研工作中,常用HE染色对正常组织和病变组织进行形态结构观察。对于确定或鉴别病变组织、细胞中出现的某些异常物质与特殊成分,需要采用特殊染色方法、酶组织化学方法或免疫组织化学方法,这些也是在观察HE染色组织切片的基础上进行的。质量好的HE染色切片是病理医生得以做出正确诊断的关键,临床上大多数病理结果误诊误判是由于切片染色质量差造成的。Hematoxylin-eosin staining (HE staining for short) is the most basic and important staining method in routine pathological slide preparation, and is widely used clinically. Hematoxylin is a basic dye that can stain the nucleus blue; eosin is an acid dye that can stain the cytoplasm red. In pathological diagnosis, teaching and scientific research, HE staining is often used to observe the morphology and structure of normal and diseased tissues. To determine or identify certain abnormal substances and special components in diseased tissues and cells, special staining methods, enzyme histochemical methods or immunohistochemical methods are required, which are also based on the observation of HE-stained tissue sections. High-quality HE-stained sections are the key to pathologists making correct diagnoses. In clinical practice, most pathological results are misdiagnosed and misjudged due to poor staining quality of sections.
染色是生物标本制作中最重要的环节之一。将生物组织浸入染色剂内,使组织细胞的某一部分染上与其他部分不同的颜色或深度不同的颜色,产生不同的折射率,以便显微镜观察。染色后用某些特定的溶液将组织过多结合的染色剂脱去,这个过程称为分化作用,所用的溶液称为分化液。在常规HE染色中,常用1%盐酸乙醇作为分化液,酸能破坏苏木素的醌型结构,使组织与色素分离而退色。经苏木素染色后,必须用1%盐酸乙醇分化,使细胞核过多结合的苏木素染料和细胞质吸附的苏木素染料脱去,再进行伊红染色,才能保证细胞核与细胞质染色层次分明、具有对比感。苏木素在酸性条件下处于红色离子状态,呈红色;在碱性条件下处于蓝色离子状态,呈蓝色。经盐酸乙醇分化后结合苏木素染料的细胞核呈红色,需立即用水除去组织切片上的酸而中止分化,再用弱碱性液使苏木素染上的细胞核恢复蓝色,这个过程称为返蓝作用或蓝化作用。Staining is one of the most important steps in the preparation of biological specimens. The biological tissue is immersed in the staining agent, so that a certain part of the tissue cells is stained with a different color or a different depth of color from other parts, resulting in different refractive indices for microscope observation. After staining, some specific solutions are used to remove the excessively combined staining agent of the tissue. This process is called differentiation, and the solution used is called differentiation solution. In conventional HE staining, 1% hydrochloric acid ethanol is commonly used as the differentiation solution, and the acid can destroy the quinone structure of hematoxylin, so that the tissue and the pigment are separated and faded. After hematoxylin staining, it must be differentiated with 1% hydrochloric acid ethanol to remove the excessively bound hematoxylin dye of the cell nucleus and the hematoxylin dye adsorbed by the cytoplasm, and then perform eosin staining to ensure that the nuclei and cytoplasm staining layers are distinct and have a sense of contrast. Hematoxylin is in a red ion state under acidic conditions and appears red; in alkaline conditions it is in a blue ion state and appears blue. After hydrochloric acid ethanol differentiation, the nuclei combined with hematoxylin dye are red, and the acid on the tissue section needs to be removed with water immediately to stop the differentiation, and then the nuclei stained with hematoxylin can be restored to blue with a weak alkaline solution. This process is called blue reversion or Blue effect.
目前常规HE染色采用的是苏木素和伊红分开染色的方法,不仅操作复杂、耗费时间长,而且需经历返蓝、分化等步骤,导致细胞核和细胞质的染色深浅程度不易掌握。例如,苏木素染液染色时间过长、分化时间过短,可导致细胞核过染,核膜、核仁等不清晰;冲洗不充分可使细胞质含有大量的苏木素染色液,导致细胞核与细胞质染色比例失调;苏木素染液染色后返蓝不足,或者切片在苏木素染色液中停留时间太短,或者分化时间过长,可导致细胞核染色不清晰;返蓝液残留过多可导致伊红拒染,使得伊红染色太淡或染色不均匀;伊红染色时间过长可导致细胞核与细胞质染色缺乏对比。At present, conventional HE staining adopts the method of separate staining of hematoxylin and eosin, which is not only complicated and time-consuming, but also needs to go through steps such as bluing and differentiation, which makes it difficult to grasp the degree of staining of the nucleus and cytoplasm. For example, if the staining time of hematoxylin staining solution is too long and the differentiation time is too short, the nuclei will be overstained, and the nuclear membrane and nucleolus will not be clear. ; Insufficient blue return after staining with hematoxylin staining solution, or the section stays in the hematoxylin staining solution for too short a time, or the differentiation time is too long, which can lead to unclear staining of the nucleus; too much residual blue returning solution can lead to eosin rejection, making eosin Red staining is too light or uneven; eosin staining for too long can result in a lack of contrast between nuclear and cytoplasmic staining.
体内各种细胞,虽然大小不一、形态各异,功能也不相同,但它们的基本结构是相同的。细胞是由细胞核、细胞质和细胞膜组成。细胞核内染色质的主要成分是DNA,在DNA双螺旋结构中,两条核苷酸链上的磷酸基向外,使DNA双螺旋的外侧带负电荷,呈酸性,很容易与带正电荷的苏木素碱性染料以离子键或氢键结合而被染色。细胞质的主要化学成分是蛋白质,我们知道蛋白质在溶液中有两性电离现象。每一种蛋白质都存在一个pH值,可使其表面净电荷为零,该pH值即为蛋白质的等电点。当pH>等电点时,该蛋白质带负电荷;反之pH<等电点时,该蛋白质带正电荷;当pH=等电点时,该蛋白质不带电荷。由于细胞质的等电点为4.7~5.0,而胞质环境pH值为6.7~6.8,大于等电点的pH值,因此细胞质蛋白质表现为带负电荷,就可能被携带正电荷的苏木素碱性染料染色,从而造成细胞核与细胞质染色难以区分的现象。All kinds of cells in the body have different sizes, shapes and functions, but their basic structure is the same. Cells are composed of nucleus, cytoplasm and cell membrane. The main component of chromatin in the nucleus is DNA. In the DNA double helix structure, the phosphate groups on the two nucleotide chains face outward, making the outside of the DNA double helix negatively charged and acidic, and it is easy to mix with the positively charged Hematoxylin basic dyes are dyed by ionic bonds or hydrogen bonds. The main chemical component of cytoplasm is protein, we know that protein has amphoteric ionization phenomenon in solution. Every protein has a pH value that can make its surface net charge zero, and this pH value is the isoelectric point of the protein. When pH>isoelectric point, the protein is negatively charged; otherwise, when pH<isoelectric point, the protein is positively charged; when pH=isoelectric point, the protein is uncharged. Since the isoelectric point of the cytoplasm is 4.7~5.0, and the pH value of the cytoplasmic environment is 6.7~6.8, which is greater than the pH value of the isoelectric point, the cytoplasmic protein appears to be negatively charged, and it may be detected by the positively charged hematoxylin basic dye. staining, resulting in indistinguishable nuclear and cytoplasmic staining.
发明内容Contents of the invention
本发明是在常规HE染色方法基础上进行改进,实现细胞核和细胞质染色一步完成,不仅能简化操作步骤、缩短操作时间,而且能解决常规HE染色中存在的细胞核和细胞质染色深浅程度不易掌握的问题。The present invention is improved on the basis of the conventional HE staining method, and realizes one-step staining of the nucleus and cytoplasm, which not only simplifies the operation steps and shortens the operation time, but also solves the problem that the degree of staining of the nucleus and cytoplasm in conventional HE staining is difficult to grasp. .
苏木素-伊红一步法染色液是本发明的根本和核心,其特征在于:主要由苏木素(0.5~10%)、媒染剂(1~5%)、促染剂(0.1~1%)、伊红Y(0.5~10%)、防腐剂(0.01~0.1%)、氧化剂(1~2%)、蒸馏水等成份组成,可实现一步完成细胞质和细胞核的染色,染色均匀清晰、层次感强,染色质量得到保证,为临床实现快速、准确病理诊断提供了有利条件。The hematoxylin-eosin one-step dyeing solution is the root and core of the present invention, and is characterized in that: it mainly consists of hematoxylin (0.5-10%), mordant (1-5%), dyeing accelerator (0.1-1%), iodine Red Y (0.5~10%), preservative (0.01~0.1%), oxidizing agent (1~2%), distilled water and other ingredients can realize the staining of cytoplasm and nucleus in one step, the staining is uniform and clear, the sense of hierarchy is strong, and the dyeing The quality is guaranteed, which provides favorable conditions for the clinical realization of rapid and accurate pathological diagnosis.
染色前后切片用特定pH值缓冲液冲洗是本发明实施成功的关键。特定pH值缓冲液的配制,其特征在于:由弱酸及其盐的混合溶液或弱碱及其盐的混合溶液配置的pH为3.6~4.7之间的缓冲液。因为细胞核和细胞质等电点的不同,细胞核约为3.3~3.6,细胞质约为4.7~5.0,我们将染色环境pH值调整到大于细胞核等电点而小于细胞质等电点的范围,即在3.6~4.7之间,这时恰好细胞核带负电荷与碱性染料结合,而细胞质带正电荷与酸性染料结合,从而使一步法染色液中所含的苏木素只染细胞核、伊红只染细胞质,而且细胞核和细胞质的染色能明显区分开,达到既能成功染色又可简化染色步骤的目的。The key to the successful implementation of the present invention is that the section is washed with a specific pH buffer solution before and after staining. The preparation of the buffer solution with a specific pH value is characterized in that: the buffer solution with a pH between 3.6 and 4.7 is prepared from a mixed solution of a weak acid and its salt or a mixed solution of a weak base and its salt. Because the isoelectric points of the nucleus and cytoplasm are different, the nucleus is about 3.3~3.6, and the cytoplasm is about 4.7~5.0. We adjust the pH value of the staining environment to be greater than the isoelectric point of the nucleus but less than the isoelectric point of the cytoplasm, that is, 3.6~ Between 4.7, at this time, the negative charge of the cell nucleus is combined with the basic dye, and the positive charge of the cytoplasm is combined with the acid dye, so that the hematoxylin contained in the one-step staining solution only stains the nucleus, and the eosin only stains the cytoplasm, and the nucleus It can be clearly distinguished from cytoplasmic staining, achieving the purpose of both successful staining and simplified staining steps.
本发明可实现苏木素染色和伊红染色一步完成,省略了分化、返蓝等容易导致染色失败的步骤,其特征在于:苏木素-伊红一步染色法的操作步骤,包括:The present invention can realize hematoxylin staining and eosin staining in one step, and omits steps such as differentiation and bluing that easily lead to staining failure, and is characterized in that the operation steps of the hematoxylin-eosin one-step staining method include:
(1)病理切片在染色前行常规脱蜡等处理,之后用特定pH值缓冲液冲洗;(1) The pathological sections are routinely dewaxed before staining, and then washed with a specific pH buffer;
(2)病理切片用苏木素-伊红一步法染色液进行染色;(2) Pathological sections were stained with hematoxylin-eosin one-step staining solution;
(3)染色后病理切片用特定pH值缓冲液冲洗,再进行常规脱水、透明、封片等操作;(4)染色结果判断:细胞核呈蓝色,细胞质呈红色。(3) After staining, the pathological sections were washed with a buffer solution with a specific pH value, and then subjected to routine dehydration, transparency, and sealing; (4) Judgment of staining results: the nucleus was blue, and the cytoplasm was red.
本发明适用于常规福尔马林固定、石蜡包埋组织切片的染色,也可用于冰冻组织切片或培养细胞的染色。采用本发明处理的组织切片,细胞核呈蓝色,细胞质呈红色,二者形成鲜明对比,易于观察分析。本发明已做过人体淋巴结、子宫、胃粘膜、大肠、甲状腺等部位的病理组织切片染色,达到了标准的HE染色效果。本发明染色效果良好、结果稳定,是一种值得推广的新型HE染色方法。The invention is suitable for staining conventional formalin-fixed and paraffin-embedded tissue sections, and can also be used for staining frozen tissue sections or cultured cells. The tissue section processed by the present invention has a blue nucleus and a red cytoplasm, which form a sharp contrast and are easy to observe and analyze. The present invention has done staining of pathological tissue sections of human lymph nodes, uterus, gastric mucosa, large intestine, thyroid gland and other parts, and has reached the standard HE staining effect. The invention has good dyeing effect and stable result, and is a novel HE dyeing method worthy of popularization.
本发明主要用于医院病理科、检验科及科研实验室,主要成份均为无生物活性的化学试剂,稳定性较好,可存放于室温条件。本发明适用于所有的人体和动物组织细胞制片的染色以及各级医院推广使用,为临床实现快速、准确病理诊断提供了有利条件。The invention is mainly used in hospital pathology departments, laboratory departments and scientific research laboratories, and its main components are chemical reagents without biological activity, which has good stability and can be stored at room temperature. The invention is applicable to the staining of all human and animal tissue cell slices and the popularization and use in hospitals at all levels, and provides favorable conditions for realizing rapid and accurate pathological diagnosis in clinic.
附图说明Description of drawings
图1为常规HE染色效果图(甲状腺)。Figure 1 is the result of conventional HE staining (thyroid).
图2为本发明的染色效果图(甲状腺)。Fig. 2 is the dyeing effect diagram (thyroid gland) of the present invention.
图3为常规HE染色效果图(子宫壁)。Figure 3 is the rendering of conventional HE staining (uterine wall).
图4为本发明的染色效果图(子宫壁)。Fig. 4 is a dyeing effect diagram (uterine wall) of the present invention.
具体实施方式detailed description
现以常规福尔马林固定、石蜡包埋病理组织切片为例,将常规HE染色和本发明的操作步骤介绍如下。Taking conventional formalin-fixed and paraffin-embedded pathological tissue sections as an example, conventional HE staining and the operation steps of the present invention are introduced as follows.
常规HE染色法的操作步骤。Operation steps of conventional HE staining method.
1、切片脱蜡至水。1. Dewax the slices to water.
①二甲苯作用2次,每次5~10min。①Two times of xylene, 5-10 minutes each time.
②无水乙醇作用2次,每次3~5min。②The effect of absolute ethanol is applied twice, each time for 3-5 minutes.
③95%的乙醇3~5min。③ 95% ethanol for 3 to 5 minutes.
④90%的乙醇3~5min。④ 90% ethanol for 3 to 5 minutes.
⑤80%的乙醇3~5min。⑤ 80% ethanol for 3 to 5 minutes.
⑥自来水或蒸馏水冲洗1~3min。⑥ Rinse with tap water or distilled water for 1-3 minutes.
2.、HE染色。2. HE staining.
①改良Lillie-Mayer苏木素染色液染色1~5min。① Stain with modified Lillie-Mayer hematoxylin staining solution for 1-5 minutes.
②自来水或蒸馏水冲洗10~30s。②Rinse with tap water or distilled water for 10-30 seconds.
③1%盐酸乙醇分化2~5s。③ 1% hydrochloric acid ethanol differentiation 2 ~ 5s.
④自来水或蒸馏水冲洗10~30s。④Rinse with tap water or distilled water for 10-30 seconds.
⑤弱碱性水(如0.2%氨水或1%碳酸锂)返蓝30~60s。⑤ Weak alkaline water (such as 0.2% ammonia water or 1% lithium carbonate) turns blue for 30-60 seconds.
⑥自来水或蒸馏水冲洗10~30s。⑥ Rinse with tap water or distilled water for 10-30 seconds.
⑦伊红染色液染色1~3min。⑦ Stain with eosin staining solution for 1-3 minutes.
⑧自来水或蒸馏水冲洗30~60s。⑧ Rinse with tap water or distilled water for 30-60 seconds.
3、脱水、透明、封片。3. Dehydration, transparency, and sealing.
①80%乙醇10~20s。① 80% ethanol for 10-20 seconds.
②90%乙醇10~20s。② 90% ethanol for 10-20 seconds.
③95%乙醇作用2次,每次1~2min。③ 95% ethanol for 2 times, each time for 1 to 2 minutes.
④无水乙醇作用2次,每次2~3min。④The effect of absolute ethanol is applied twice, each time for 2 to 3 minutes.
⑤二甲苯透明3次,每次2~3min。⑤ Xylene transparent 3 times, 2 to 3 minutes each time.
⑥中性树脂封片。⑥ Mount with neutral resin.
4、染色结果:细胞核呈蓝色;细胞质、肌纤维、胶原纤维、甲状腺胶质等呈深浅不一的红色;角蛋白、红细胞等呈明亮的橙红色。4. Staining results: cell nuclei are blue; cytoplasm, muscle fibers, collagen fibers, thyroid jelly, etc. are red in different shades; keratin, red blood cells, etc. are bright orange red.
苏木素-伊红一步染色法的操作步骤。Procedure for one-step staining with hematoxylin-eosin.
1、切片脱蜡至水。1. Dewax the slices to water.
①二甲苯作用2次,每次5~10min。①Two times of xylene, 5-10 minutes each time.
②无水乙醇作用2次,每次3~5min。②The effect of absolute ethanol is applied twice, each time for 3-5 minutes.
③95%的乙醇3~5min。③ 95% ethanol for 3 to 5 minutes.
④90%的乙醇3~5min。④ 90% ethanol for 3 to 5 minutes.
⑤80%的乙醇3~5min。⑤ 80% ethanol for 3 to 5 minutes.
⑥特定pH值缓冲液冲洗30~60s。⑥Rinse with specific pH buffer solution for 30-60s.
2、苏木素-伊红一步法染色(省略了分化、返蓝以及中间多次冲洗步骤)。2. One-step staining with hematoxylin-eosin (differentiation, bluing and multiple washing steps in the middle are omitted).
①苏木素-伊红一步法染色液染色1~5min。① Stain with hematoxylin-eosin one-step staining solution for 1-5 minutes.
②特定pH值缓冲液冲洗30~60s。②Rinse with specific pH buffer solution for 30-60s.
3、脱水、透明、封片(具体步骤同常规HE染色)。3. Dehydration, transparency, and mounting (the specific steps are the same as conventional HE staining).
4、染色结果同常规HE染色。4. The staining result is the same as conventional HE staining.
以上所述仅为本发明的优选实施方式。本技术领域的普通技术人员应该了解,本发明不受上述实施例的限制,在不脱离本发明原理的前提下,本发明还可作出若干变化和改进,这些变化和改进也应视为本发明的保护范围。The above are only preferred embodiments of the present invention. It should be understood by those of ordinary skill in the art that the present invention is not limited by the above-mentioned embodiments. Under the premise of not departing from the principle of the present invention, the present invention can also make some changes and improvements, and these changes and improvements should also be regarded as the present invention. scope of protection.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710009899.7A CN106644656B (en) | 2017-01-06 | 2017-01-06 | hematoxylin-eosin one-step staining |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710009899.7A CN106644656B (en) | 2017-01-06 | 2017-01-06 | hematoxylin-eosin one-step staining |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106644656A true CN106644656A (en) | 2017-05-10 |
CN106644656B CN106644656B (en) | 2019-01-22 |
Family
ID=58843368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710009899.7A Expired - Fee Related CN106644656B (en) | 2017-01-06 | 2017-01-06 | hematoxylin-eosin one-step staining |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106644656B (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107319581A (en) * | 2017-08-15 | 2017-11-07 | 合肥明英富海生物科技有限公司 | A kind of processing method of the fan assembly of tea seed processing hulling device |
CN108414328A (en) * | 2018-04-04 | 2018-08-17 | 南京烁朴生物科技有限公司 | A kind of modified form hematoxylin dyeing liquor reagent, preparation method and colouring method |
CN109115543A (en) * | 2018-07-09 | 2019-01-01 | 苏州华测生物技术有限公司 | A method of it effectively improving experimental animal Parathyroid Tissue pathology film-making and cuts out rate |
CN109490049A (en) * | 2018-12-27 | 2019-03-19 | 大连大学 | A kind of haematoxylin dyeing liquid and preparation method |
CN110553889A (en) * | 2019-09-18 | 2019-12-10 | 宋建华 | he dyeing process of automatic dyeing machine |
CN111492224A (en) * | 2017-12-24 | 2020-08-04 | 文塔纳医疗系统公司 | Eosin staining technique |
CN111766125A (en) * | 2020-07-29 | 2020-10-13 | 广州金域医学检验中心有限公司 | Dyeing method using fluorescence quenching time difference and automatic dyeing device, equipment and medium |
CN112857948A (en) * | 2021-01-26 | 2021-05-28 | 广州安必平医药科技股份有限公司 | Hematoxylin-eosin improvement reagent and rapid staining method thereof |
US20210215579A1 (en) * | 2020-01-13 | 2021-07-15 | Samsung Life Public Welfare Foundation | Tissue staining composition and tissue staining method using same |
CN113588383A (en) * | 2021-06-15 | 2021-11-02 | 北京清华长庚医院 | HE staining method for liver pathological large section |
CN114279795A (en) * | 2020-09-28 | 2022-04-05 | 成都天士力诺唯生物科技有限公司 | Rapid detection system, detection method and application of tissue sample |
CN114316967A (en) * | 2021-12-31 | 2022-04-12 | 湖南智享未来生物科技有限公司 | Carbon dot composition, preparation method and application in cell nucleus and membrane co-staining |
CN114441272A (en) * | 2022-01-27 | 2022-05-06 | 北京艾迪康医学检验实验室有限公司 | Exfoliative cell staining solution and preparation method thereof |
CN115014909A (en) * | 2022-06-13 | 2022-09-06 | 四川金域医学检验中心有限公司 | Efficient staining process method suitable for pathological tissues |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103725040A (en) * | 2013-12-31 | 2014-04-16 | 江苏省原子医学研究所 | Hematoxylin eosin staining solution and preparation method thereof |
CN104471405A (en) * | 2012-01-26 | 2015-03-25 | 莱卡生物系统里士满股份有限公司 | Methods and compositions for hematoxylin and eosin staining |
US20160153871A1 (en) * | 2014-11-29 | 2016-06-02 | Jerry Fredenburgh | Cytoplasmic Stain Composition |
CN105651580A (en) * | 2015-12-28 | 2016-06-08 | 北京雷根生物技术有限公司 | Hematoxylin-eosin mixed staining solution |
CN105699155A (en) * | 2016-01-29 | 2016-06-22 | 山东省千佛山医院 | Chemical dyeing detection method for brain-derived neurotrophic factor BDNF specimen of intestinal mucosa |
-
2017
- 2017-01-06 CN CN201710009899.7A patent/CN106644656B/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104471405A (en) * | 2012-01-26 | 2015-03-25 | 莱卡生物系统里士满股份有限公司 | Methods and compositions for hematoxylin and eosin staining |
CN103725040A (en) * | 2013-12-31 | 2014-04-16 | 江苏省原子医学研究所 | Hematoxylin eosin staining solution and preparation method thereof |
US20160153871A1 (en) * | 2014-11-29 | 2016-06-02 | Jerry Fredenburgh | Cytoplasmic Stain Composition |
CN105651580A (en) * | 2015-12-28 | 2016-06-08 | 北京雷根生物技术有限公司 | Hematoxylin-eosin mixed staining solution |
CN105699155A (en) * | 2016-01-29 | 2016-06-22 | 山东省千佛山医院 | Chemical dyeing detection method for brain-derived neurotrophic factor BDNF specimen of intestinal mucosa |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107319581A (en) * | 2017-08-15 | 2017-11-07 | 合肥明英富海生物科技有限公司 | A kind of processing method of the fan assembly of tea seed processing hulling device |
CN111492224A (en) * | 2017-12-24 | 2020-08-04 | 文塔纳医疗系统公司 | Eosin staining technique |
CN108414328A (en) * | 2018-04-04 | 2018-08-17 | 南京烁朴生物科技有限公司 | A kind of modified form hematoxylin dyeing liquor reagent, preparation method and colouring method |
CN109115543B (en) * | 2018-07-09 | 2021-06-22 | 苏州华测生物技术有限公司 | Method for effectively improving pathological slicing cut-out rate of parathyroid gland tissue of experimental animal |
CN109115543A (en) * | 2018-07-09 | 2019-01-01 | 苏州华测生物技术有限公司 | A method of it effectively improving experimental animal Parathyroid Tissue pathology film-making and cuts out rate |
CN109490049A (en) * | 2018-12-27 | 2019-03-19 | 大连大学 | A kind of haematoxylin dyeing liquid and preparation method |
CN110553889A (en) * | 2019-09-18 | 2019-12-10 | 宋建华 | he dyeing process of automatic dyeing machine |
US20210215579A1 (en) * | 2020-01-13 | 2021-07-15 | Samsung Life Public Welfare Foundation | Tissue staining composition and tissue staining method using same |
KR20210090849A (en) * | 2020-01-13 | 2021-07-21 | 사회복지법인 삼성생명공익재단 | Tissue Dyeing Composition and Tissue Dyeing Method Using the Same |
KR102332433B1 (en) * | 2020-01-13 | 2021-11-30 | 사회복지법인 삼성생명공익재단 | Tissue Dyeing Composition and Tissue Dyeing Method Using the Same |
US11846576B2 (en) | 2020-01-13 | 2023-12-19 | Samsung Life Public Welfare Foundation | Tissue staining composition and tissue staining method using same |
CN111766125A (en) * | 2020-07-29 | 2020-10-13 | 广州金域医学检验中心有限公司 | Dyeing method using fluorescence quenching time difference and automatic dyeing device, equipment and medium |
CN114279795A (en) * | 2020-09-28 | 2022-04-05 | 成都天士力诺唯生物科技有限公司 | Rapid detection system, detection method and application of tissue sample |
CN112857948A (en) * | 2021-01-26 | 2021-05-28 | 广州安必平医药科技股份有限公司 | Hematoxylin-eosin improvement reagent and rapid staining method thereof |
CN113588383A (en) * | 2021-06-15 | 2021-11-02 | 北京清华长庚医院 | HE staining method for liver pathological large section |
CN114316967A (en) * | 2021-12-31 | 2022-04-12 | 湖南智享未来生物科技有限公司 | Carbon dot composition, preparation method and application in cell nucleus and membrane co-staining |
CN114316967B (en) * | 2021-12-31 | 2023-04-14 | 湖南智享未来生物科技有限公司 | Carbon dot composition, preparation method and application in cell nucleus and membrane co-staining |
CN114441272A (en) * | 2022-01-27 | 2022-05-06 | 北京艾迪康医学检验实验室有限公司 | Exfoliative cell staining solution and preparation method thereof |
CN115014909A (en) * | 2022-06-13 | 2022-09-06 | 四川金域医学检验中心有限公司 | Efficient staining process method suitable for pathological tissues |
Also Published As
Publication number | Publication date |
---|---|
CN106644656B (en) | 2019-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106644656A (en) | Hematoxylin-eosin one-step dyeing method | |
CN107490511B (en) | A kind of haematoxylin dyeing liquid and HE colouring method | |
CN105651580B (en) | A kind of dyed blended liquid in haematoxylin Yihong | |
Jordan | A Text-book of Histology | |
CN103740811B (en) | Chromosome karyotype analysis marrow G is with preparation method | |
CN104155160A (en) | Tissue dewaxing transparent agent free of benzene | |
CN103033409B (en) | The histocyte colouring method improved and application thereof | |
CN105755099A (en) | Papanicolaou staining solution and preparation method thereof | |
CN103525119B (en) | A kind of cartilage staining fluid, bone stain method and utilize the method to prepare the method for embryo's skeleton specimen | |
CN109946139A (en) | A kind of paraffin section immunohistochemical overstaining PAS kit and its staining method and application | |
CN118090377B (en) | A kit and staining method for special light microscopic staining of renal puncture tissue biopsy | |
CN105842037B (en) | Colouring method that is a kind of while showing mast cell and acidophic cell | |
CN105950700A (en) | Fungus fluorescent staining agent | |
CN109612807A (en) | A kind of urinary formed element dyeing liquor | |
CN109490268A (en) | A kind of fluorescence microscopy method of efficient, high-definition observation of plant pollen tube growing state in gynoecium | |
CN104977194A (en) | A method of adding graphene to accelerate sample processing | |
CN115436623A (en) | Kidney tissue paraffin section IV type collagen alpha 3 and alpha 4 chain immunofluorescence method | |
Hasan et al. | A better and copacetic protocol for histopathological slide preparation using H&E stain: A review | |
CN101923019A (en) | Method for restoring color of faded pathological HE section | |
CN111829859A (en) | A kind of high-efficiency poplar seed transparent dyeing and its three-dimensional imaging method | |
CN104458386B (en) | Staining method for thrombus compositions and application of staining method | |
CN115308006B (en) | Improved myelin staining kit and staining method thereof | |
CN113933133A (en) | A staining solution for cell samples | |
CN112816295A (en) | Bone marrow tissue decalcification liquid and method for preparing bone marrow tissue paraffin section | |
CN107490506B (en) | The immediate processing method of pathological diagnosis kit and tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190122 |
|
CF01 | Termination of patent right due to non-payment of annual fee |